SK Bioscience Co Ltd

Common Name
SK Bioscience
Country
South Korea
Sector
Healthcare
Industry
Biotechnology
Employees
984
Ticker
302440
Exchange
KOREA EXCHANGE
Description
Sk Bioscience Co., Ltd. is a South Korean biopharmaceutical company that specializes in the development, manufacturing, and distribution of vaccines. As a key player in the healthcare sector, the comp...

SK Bioscience's GHG Emissions Data Preview

In 2023, SK Bioscience completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).

However, SK Bioscience has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into SK Bioscience's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of SK Bioscience amounted to 19,616 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).

Compared to 2022, the total operational greenhouse gas (GHG) emissions of SK Bioscience increased by 6.07%, suggesting that the company faced challenges in reducing its emissions from its core operations.

SK Bioscience's Scope 1 Emissions Over Time

2019202020212022202301.5 k3 k4.5 k6 ktCO2e+10%+21%+6%+13%
  • Total Scope 1
  • Year-over-Year Change

What are SK Bioscience's Scope 1 emissions?

In 2023, the total Scope 1 emissions of SK Bioscience were 5,863 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

Has SK Bioscience reduced its Scope 1 emissions over time?

Since 2019, SK Bioscience's Scope 1 emissions have increased by 60.15%, reflecting a rising long-term trend in Scope 1 emissions over time.

Compared to the previous year (2022), SK Bioscience's Scope 1 emissions increased by 13.34%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.

What are SK Bioscience's Scope 2 emissions?

In 2023, SK Bioscience reported Scope 2 greenhouse gas (GHG) emissions of 13,753 tCOâ‚‚e without specifying the calculation method.

Has SK Bioscience reduced its Scope 2 emissions over time?

Since 2019, SK Bioscience's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 52.54%, reflecting a rising long-term trend in Scope 2 emissions over time.

Compared to the previous year (2022), SK Bioscience's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that SK Bioscience 's emissions have plateaued with no significant change in its energy consumption footprint.

What methodology does SK Bioscience use for Scope 2 reporting?

In 2023, SK Bioscience reported its Scope 2 emissions using an unspecified methodology.

SK Bioscience's Scope 2 Emissions Over Time

2019202020212022202303.5 k7 k10.5 k14 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into SK Bioscience's Value Chain Emissions

In 2023, SK Bioscience reported 116,063 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.

The 2023 disclosure of SK Bioscience includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year.

SK Bioscience's Scope 3 Emissions Over Time

202120222023040 k80 k120 k160 ktCO2e-35%+17%
  • Total Scope 3
  • Year-over-Year Change

What are SK Bioscience's Scope 3 emissions?

In 2023, SK Bioscience reported total Scope 3 emissions of 116,063 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

Compared to the previous year (2022), SK Bioscience's Scope 3 emissions increased by 16.87%, suggesting that the company faced challenges in reducing emissions across its value chain.

Insights into SK Bioscience's Total Carbon Footprint

In 2023, SK Bioscience reported a total carbon footprint of 135,679 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 15.18% increase compared to 2022, suggesting a rise in emissions across its operations or value chain.

The largest contributor to SK Bioscience's total carbon footprint was Scope 3 emissions, accounting for 85.54% of the company's total carbon footprint, followed by Scope 2 emissions at 10.14%.

Want Full Access to SK Bioscience's GHG Emissions Dataset?
Sign Up